246 related articles for article (PubMed ID: 27483324)
1. Telomerase: The Devil Inside.
Kumar M; Lechel A; Güneş Ç
Genes (Basel); 2016 Jul; 7(8):. PubMed ID: 27483324
[TBL] [Abstract][Full Text] [Related]
2. Telomerase reverse transcriptase expression protects transformed human cells against DNA-damaging agents, and increases tolerance to chromosomal instability.
Fleisig HB; Hukezalie KR; Thompson CA; Au-Yeung TT; Ludlow AT; Zhao CR; Wong JM
Oncogene; 2016 Jan; 35(2):218-27. PubMed ID: 25893297
[TBL] [Abstract][Full Text] [Related]
3. Implications of telomeres and telomerase in endometrial pathology.
Hapangama DK; Kamal A; Saretzki G
Hum Reprod Update; 2017 Mar; 23(2):166-187. PubMed ID: 27979878
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of telomerase induces alternative lengthening of telomeres during human esophageal carcinogenesis.
Queisser A; Heeg S; Thaler M; von Werder A; Opitz OG
Cancer Genet; 2013 Nov; 206(11):374-86. PubMed ID: 24331919
[TBL] [Abstract][Full Text] [Related]
5. Telomere lengthening in telomerase-negative cells: the ends are coming together.
Scheel C; Poremba C
Virchows Arch; 2002 Jun; 440(6):573-82. PubMed ID: 12070595
[TBL] [Abstract][Full Text] [Related]
6. Variations in telomere maintenance and the role of telomerase inhibition in gastrointestinal cancer.
Heeg S
Pharmgenomics Pers Med; 2015; 8():171-80. PubMed ID: 26675332
[TBL] [Abstract][Full Text] [Related]
7. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
Babizhayev MA; Yegorov YE
J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
[TBL] [Abstract][Full Text] [Related]
8. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
9. Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications.
Liu T; Yuan X; Xu D
Genes (Basel); 2016 Jul; 7(7):. PubMed ID: 27438857
[TBL] [Abstract][Full Text] [Related]
10. Ageing and cancer: the telomere and telomerase connection.
Shay JW; Wright WE
Novartis Found Symp; 2001; 235():116-25; discussion 125-9, 146-9. PubMed ID: 11280022
[TBL] [Abstract][Full Text] [Related]
11. [The role of telomere-binding proteins in carcinogenesis].
Aragona M; Pontoriero A; Panetta S; La Torre I; La Torre F
Minerva Med; 2000; 91(11-12):299-304. PubMed ID: 11253711
[TBL] [Abstract][Full Text] [Related]
12. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
Nittis T; Guittat L; Stewart SA
Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854
[TBL] [Abstract][Full Text] [Related]
13. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
[TBL] [Abstract][Full Text] [Related]
14. Absence of telomerase reverse transcriptase promoter mutations in neuroblastoma.
Lindner S; Bachmann HS; Odersky A; Schaefers S; Klein-Hitpass L; Hero B; Fischer M; Eggert A; Schramm A; Schulte JH
Biomed Rep; 2015 Jul; 3(4):443-446. PubMed ID: 26171145
[TBL] [Abstract][Full Text] [Related]
15. Implications of telomere-independent activities of telomerase reverse transcriptase in human cancer.
Ding D; Zhou J; Wang M; Cong YS
FEBS J; 2013 Jul; 280(14):3205-11. PubMed ID: 23527617
[TBL] [Abstract][Full Text] [Related]
16. Telomerase inhibition alters telomere maintenance mechanisms in laryngeal squamous carcinoma cells.
Chen W; Chen SM; Yu Y; Xiao BK; Huang ZW; Tao ZZ
J Laryngol Otol; 2010 Jul; 124(7):778-83. PubMed ID: 20403221
[TBL] [Abstract][Full Text] [Related]
17. Telomeres and telomerase in sarcomas.
Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Ochi M
Anticancer Res; 2009 Oct; 29(10):3833-6. PubMed ID: 19846916
[TBL] [Abstract][Full Text] [Related]
18. Telomere and telomerase in stem cells.
Hiyama E; Hiyama K
Br J Cancer; 2007 Apr; 96(7):1020-4. PubMed ID: 17353922
[TBL] [Abstract][Full Text] [Related]
19. Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
Zaffaroni N; Villa R; Pastorino U; Cirincione R; Incarbone M; Alloisio M; Curto M; Pilotti S; Daidone MG
Clin Cancer Res; 2005 Apr; 11(8):2832-9. PubMed ID: 15837730
[TBL] [Abstract][Full Text] [Related]
20. Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation.
Marie-Egyptienne DT; Brault ME; Zhu S; Autexier C
Exp Cell Res; 2008 Feb; 314(3):668-75. PubMed ID: 18067891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]